Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.9 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |